Advertisement
Japan
This Week in AsiaHealth & Environment

Japanese scientists’ non-addictive painkiller offers hope in combating opioid crisis

If larger-scale trials in the US prove successful, the drug could go on the market in about two years, the Kyoto University team says

Reading Time:2 minutes
Why you can trust SCMP
A Drug Enforcement Administration chemist checks confiscated pills containing fentanyl. Photo: AFP
Julian Ryall
A team of Japanese scientists has developed a new painkiller they say is as effective as fentanyl but without its addictive properties, a breakthrough that could reshape the fight against the global opioid crisis if clinical trials succeed.

The team from Kyoto University has been working on the project for 13 years, with phase one clinical trials already proving successful and phase two trials due to start soon.

Masatoshi Hagiwara, a professor of pharmaceutical medicine at the university, hopes that larger-scale clinical trials will take place in the US next year and that the drug can be commercially available in around two years.
Advertisement

For Hagiwara, developing the painkiller is personal.

“My father, who was a doctor, died about 20 years ago of gall bladder cancer,” he told This Week in Asia. “The cancer was not the direct cause of his death; it was the morphine-based painkillers that he had to take to control the pain that eventually stopped his breathing. That is one of the typical adverse effects of morphine-based painkillers.”

Kyoto University professor Masatoshi Hagiwara in his lab. Photo: Handout
Kyoto University professor Masatoshi Hagiwara in his lab. Photo: Handout

The team’s new drug was able to eliminate pain without the side effects, even permitting the patient to remain fully conscious, he said, adding that one of the greatest benefits was that patients do not develop dependence.

Advertisement
Select Voice
Choose your listening speed
Get through articles 2x faster
1.25x
250 WPM
Slow
Average
Fast
1.25x